Cannabics Pharmaceuticals Inc buy melinda
Start price
02.01.18
/
50%
€2.10
Target price
03.07.18
€4.00
Performance (%)
-63.24%
End price
03.07.18
€0.77
Summary
This prediction ended on 03.07.18 with a price of €0.77. The BUY prediction by melinda for Cannabics Pharmaceuticals Inc performed very badly with a performance of -63.24%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cannabics Pharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
Comments by melinda for this prediction
In the thread Cannabics Pharmaceuticals Inc diskutieren
wir erwarten
a +
(Laufzeit überschritten)
Stopped prediction by melinda for Cannabics Pharmaceuticals Inc
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.84
24.08.17
24.08.17
€2.00
02.01.18
02.01.18
151.31%
02.01.18
02.01.18
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€4.25
22.02.17
22.02.17
€7.00
22.08.17
22.08.17
-80.02%
22.08.17
22.08.17
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.99
21.02.17
21.02.17
€7.00
22.02.17
22.02.17
16.86%
22.02.17
22.02.17
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.33
21.02.17
21.02.17
€6.00
21.02.17
21.02.17
14.11%
21.02.17
21.02.17
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€3.80
17.02.17
17.02.17
€4.00
17.02.17
17.02.17
5.26%
17.02.17
17.02.17


